Biochemical Detection of cGMP From Past to Present: An Overview

Author(s):  
Peter M. Schmidt
2021 ◽  
Vol 2 (1) ◽  
pp. 100323
Author(s):  
Anastasia Selyutina ◽  
Felipe Diaz-Griffero
Keyword(s):  

The Lancet ◽  
1998 ◽  
Vol 351 (9108) ◽  
pp. 1063-1064
Author(s):  
T McDonagh ◽  
A Harkness ◽  
HJ Dargie

The Lancet ◽  
1998 ◽  
Vol 351 (9095) ◽  
pp. 9-13 ◽  
Author(s):  
TA McDonagh ◽  
SD Robb ◽  
DR Murdoch ◽  
JJ Morton ◽  
I Ford ◽  
...  

Nephron ◽  
1995 ◽  
Vol 69 (3) ◽  
pp. 305-310 ◽  
Author(s):  
Hiroo Ito ◽  
Minoru Chimata ◽  
Megumi Oka ◽  
Yasuyuki Suzuki ◽  
Natsuko Hamada ◽  
...  

Micromachines ◽  
2021 ◽  
Vol 12 (11) ◽  
pp. 1380
Author(s):  
Binfeng Yin ◽  
Xinhua Wan ◽  
Changcheng Qian ◽  
A. S. M. Muhtasim Fuad Sohan ◽  
Teng Zhou ◽  
...  

Metal ions in high concentrations can pollute the marine environment. Human activities and industrial pollution are the causes of Cu2+ contamination. Here, we report our discovery of an enzyme method-based microfluidic that can be used to rapidly detect Cu2+ in seawater. In this method, Cu2+ is reduced to Cu+ to inhibit horseradish peroxidase (HRP) activity, which then results in the color distortion of the reaction solution. The chip provides both naked eye and spectrophotometer modalities. Cu2+ concentrations have an ideal linear relationship, with absorbance values ranging from 3.91 nM to 256 μM. The proposed enzyme method-based microfluidic chip detects Cu2+ with a limit of detection (LOD) of 0.87 nM. Other common metal ions do not affect the operation of the chip. The successful detection of Cu2+ was achieved using three real seawater samples, verifying the ability of the chip in practical applications. Furthermore, the chip realizes the functions of two AND gates in series and has potential practical implementations in biochemical detection and biological computing.


2015 ◽  
pp. 4455-4460
Author(s):  
Alexandre A. Tonin ◽  
Aleksandro S. Da Silva ◽  
Victor C. Pimentel ◽  
Daniele Zanini ◽  
Maria Rosa C. Schetinger ◽  
...  

Objective. This study aimed to investigate the presence and activity of the ecto adenosine deaminase (E-ADA) enzyme in tachyzoites of Neospora caninum (Nc-1 strain), as well as to assess the activity of a well-known E-ADA inhibitor, the deoxycoformycin. Materials and methods. The parasites were grown in cell culture, being subsequently separated in a pellet of tachyzoites, on which the E-ADA activity was tested using the concentrations 0 (control), 0.2, 0.4 and 0.8 mg mL-1. Results. The E-ADA showed high activity, progressively increasing its activity according to the enhancement of the protein concentration. The test was carried out with different concentrations of deoxycoformycin, showing that it was able to inhibit the E-ADA present on the free form of the parasite. Conclusions. Based on these results we conclude that the E-ADA is present on tachyzoites of N. caninum, and deoxycoformycin is able to inhibit this enzyme. In this sense, knowing the negative impact of N. caninum on reproductive issue in cattle (mainly abortion), might it is an alternative in order to deal with this parasitic infection.Key words: adenosine deaminase, deoxycoformycin, neosporosis (Source: CAB, MeSH).


2000 ◽  
pp. 327-330 ◽  
Author(s):  
Jin-Woo Choi ◽  
C. Ajith Wijayawardhana ◽  
Nihat Okulan ◽  
Kwang W. Oh ◽  
Arum Han ◽  
...  

2020 ◽  
Vol 20 (12) ◽  
pp. 6270-6276
Author(s):  
Jianze Huang ◽  
Yang Liu ◽  
Zhiyong Tang ◽  
Xiufeng Shao ◽  
Congchun Zhang

1983 ◽  
Vol 29 (12) ◽  
pp. 2011-2018 ◽  
Author(s):  
A F Heeley ◽  
D Watson

Abstract We examine critically the biochemical methods capable of detecting and monitoring the end-organ disease processes in patients with cystic fibrosis. Although the diagnosis of cystic fibrosis is never justified on the basis of the sweat salt test alone, the original filter-paper technic (Gibson-Cooke, Pediatrics 23:545-549, 1959) for determining Na+ and Cl- concentrations in sweat remains the most discriminating method. We discuss the contributions for neonatal screening of the so-called cystic fibrosis protein, associated decreased enzymic activities in the homo- and heterozygous state, and immunoreactive trypsin. Because evidence of either intestinal malabsorption or a pancreatic lesion must be sought, we review the use and interpretation of some tests of pancreatic dysfunction (meconium albumin, duodenal juice components, serum pancreatic isoamylase, and trypsinogen), both in establishing and in confirming the diagnosis of cystic fibrosis.


Sign in / Sign up

Export Citation Format

Share Document